Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study
Journal of Asthma and Allergy · 2026-10 · Volume 19 · 1-10
DOI: 10.2147/jaa.s652986 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Asthma and Allergy, 2026-10. Verfasst von Mathieu D Saint-Pierre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Respirology, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respirology, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada.
- Respirology, Orleans Cardiopulmonary Group, Ottawa, ON, Canada.
ORCID-Profile: Mathieu D Saint-Pierre
Zitieren
APA
Saint-Pierre, M. D., Agaybi, S., Charron, C. B., & Leduc, J. G. (2026). Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study. Journal of Asthma and Allergy, Volume 19, 1-10. https://doi.org/10.2147/jaa.s652986
Vancouver
Saint-Pierre MD, Agaybi S, Charron CB, Leduc JG. Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study. Journal of Asthma and Allergy. 2026;Volume 19:1-10. doi:10.2147/jaa.s652986
BibTeX
@article{SaintPierre2026,
author = {Saint-Pierre, Mathieu D and Agaybi, Samih and Charron, Catherine B and Leduc, Jean-Grégoire},
title = {Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study},
journal = {Journal of Asthma and Allergy},
year = {2026},
volume = {Volume 19},
pages = {1--10},
doi = {10.2147/jaa.s652986}
}
EUVIMED